276 related articles for article (PubMed ID: 12401709)
21. Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases.
Cao J; Zhou Y; Peng H; Huang X; Stahler S; Suri V; Qadri A; Gareski T; Jones J; Hahm S; Perreault M; McKew J; Shi M; Xu X; Tobin JF; Gimeno RE
J Biol Chem; 2011 Dec; 286(48):41838-41851. PubMed ID: 21990351
[TBL] [Abstract][Full Text] [Related]
22. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat.
Smith SJ; Cases S; Jensen DR; Chen HC; Sande E; Tow B; Sanan DA; Raber J; Eckel RH; Farese RV
Nat Genet; 2000 May; 25(1):87-90. PubMed ID: 10802663
[TBL] [Abstract][Full Text] [Related]
23. JTT-553, a novel Acyl CoA:diacylglycerol acyltransferase (DGAT) 1 inhibitor, improves glucose metabolism in diet-induced obesity and genetic T2DM mice.
Tomimoto D; Okuma C; Ishii Y; Kobayashi A; Ohta T; Kakutani M; Imanaka T; Ogawa N
J Pharmacol Sci; 2015 Sep; 129(1):51-8. PubMed ID: 26354408
[TBL] [Abstract][Full Text] [Related]
24. Analysis of energy expenditure at different ambient temperatures in mice lacking DGAT1.
Chen HC; Ladha Z; Smith SJ; Farese RV
Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E213-8. PubMed ID: 12388146
[TBL] [Abstract][Full Text] [Related]
25. Intestine-specific expression of acyl CoA:diacylglycerol acyltransferase 1 reverses resistance to diet-induced hepatic steatosis and obesity in Dgat1-/- mice.
Lee B; Fast AM; Zhu J; Cheng JX; Buhman KK
J Lipid Res; 2010 Jul; 51(7):1770-80. PubMed ID: 20147738
[TBL] [Abstract][Full Text] [Related]
26. Increased diacylglycerol acyltransferase activity is associated with triglyceride accumulation in tissues of diet-induced insulin-resistant hyperlipidemic hamsters.
Casaschi A; Maiyoh GK; Adeli K; Theriault AG
Metabolism; 2005 Mar; 54(3):403-9. PubMed ID: 15736121
[TBL] [Abstract][Full Text] [Related]
27. DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle.
Liu L; Yu S; Khan RS; Ables GP; Bharadwaj KG; Hu Y; Huggins LA; Eriksson JW; Buckett LK; Turnbull AV; Ginsberg HN; Blaner WS; Huang LS; Goldberg IJ
J Lipid Res; 2011 Apr; 52(4):732-44. PubMed ID: 21205704
[TBL] [Abstract][Full Text] [Related]
28. Constitutive activation of IKKβ in adipose tissue prevents diet-induced obesity in mice.
Jiao P; Feng B; Ma J; Nie Y; Paul E; Li Y; Xu H
Endocrinology; 2012 Jan; 153(1):154-65. PubMed ID: 22067324
[TBL] [Abstract][Full Text] [Related]
29. Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice.
Harada K; Shen WJ; Patel S; Natu V; Wang J; Osuga J; Ishibashi S; Kraemer FB
Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1182-95. PubMed ID: 12954598
[TBL] [Abstract][Full Text] [Related]
30. Enhancing energy and glucose metabolism by disrupting triglyceride synthesis: Lessons from mice lacking DGAT1.
Chen HC
Nutr Metab (Lond); 2006 Jan; 3():10. PubMed ID: 16448557
[TBL] [Abstract][Full Text] [Related]
31. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
Vidal-Puig A; Jimenez-Liñan M; Lowell BB; Hamann A; Hu E; Spiegelman B; Flier JS; Moller DE
J Clin Invest; 1996 Jun; 97(11):2553-61. PubMed ID: 8647948
[TBL] [Abstract][Full Text] [Related]
32. Increased serum leptin protects from adiposity despite the increased glucose uptake in white adipose tissue in mice lacking p85alpha phosphoinositide 3-kinase.
Terauchi Y; Matsui J; Kamon J; Yamauchi T; Kubota N; Komeda K; Aizawa S; Akanuma Y; Tomita M; Kadowaki T
Diabetes; 2004 Sep; 53(9):2261-70. PubMed ID: 15331535
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of [trans-5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl]acetic acid monobenzenesulfonate (JTT-553), a novel acyl CoA:diacylglycerol transferase (DGAT) 1 inhibitor.
Tomimoto D; Okuma C; Ishii Y; Akiyama Y; Ohta T; Kakutani M; Ohkuma Y; Ogawa N
Biol Pharm Bull; 2015; 38(2):263-9. PubMed ID: 25747985
[TBL] [Abstract][Full Text] [Related]
34. DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis.
Buhman KK; Smith SJ; Stone SJ; Repa JJ; Wong JS; Knapp FF; Burri BJ; Hamilton RL; Abumrad NA; Farese RV
J Biol Chem; 2002 Jul; 277(28):25474-9. PubMed ID: 11959864
[TBL] [Abstract][Full Text] [Related]
35. [Effect of Jinlida on DGAT1 in Skeletal Muscle in Fat-Induced Insulin Resistance ApoE -/- Mice].
Jin X; Zhang HX; Cui WW
Zhong Yao Cai; 2015 Jun; 38(6):1237-41. PubMed ID: 26762066
[TBL] [Abstract][Full Text] [Related]
36. Dietary Macronutrient Composition Determines the Contribution of DGAT1 to Alcoholic Steatosis.
Huang LS; Yuen JJ; Trites MJ; Saha A; Epps CT; Hu Y; Kerolle S; Lee SA; Jiang H; Goldberg IJ; Blaner WS; Clugston RD
Alcohol Clin Exp Res; 2018 Dec; 42(12):2298-2312. PubMed ID: 30192394
[TBL] [Abstract][Full Text] [Related]
37. Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice.
Tsuchiya K; Sakai H; Suzuki N; Iwashima F; Yoshimoto T; Shichiri M; Hirata Y
Endocrinology; 2007 Oct; 148(10):4548-56. PubMed ID: 17584959
[TBL] [Abstract][Full Text] [Related]
38. Leptin has acute effects on glucose and lipid metabolism in both lean and gold thioglucose-obese mice.
Bryson JM; Phuyal JL; Swan V; Caterson ID
Am J Physiol; 1999 Sep; 277(3):E417-22. PubMed ID: 10484352
[TBL] [Abstract][Full Text] [Related]
39. Prolyl hydroxylase domain protein 2 plays a critical role in diet-induced obesity and glucose intolerance.
Matsuura H; Ichiki T; Inoue E; Nomura M; Miyazaki R; Hashimoto T; Ikeda J; Takayanagi R; Fong GH; Sunagawa K
Circulation; 2013 May; 127(21):2078-87. PubMed ID: 23630130
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of triglyceride synthesis in skeletal muscle overexpressing DGAT1.
Yang F; Wei Z; Ding X; Liu X; Ge X; Song G; Li G; Guo H
Lipids Health Dis; 2013 May; 12():63. PubMed ID: 23642106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
